Cataract

• FDA approval · 2025-04-04
  FDA Approved: TISSUEBLUE — Supplemental Application (D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.)

  FDA approved TissueBlue (Brilliant Blue G) as a supplemental application, granting its use as an ocular staining dye to assist cataract surg…

• EMA approval · 2024-11-08
  EMA Authorised: Omidria (ketorolac;phenylephrine) — Rayner Surgical (Ireland) Limited

  The European Medicines Agency authorised Omidria, a fixed combination of ketorolac and phenylephrine, for use during lens implantation to re…

• FDA approval · 2019-12-20
  FDA Approved: TISSUEBLUE — Original Application (D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.)

  FDA approved TissueBlue (Brilliant Blue G) from D.O.R.C. for use as a staining dye in ophthalmic surgery to facilitate capsulorhexis during …

• FDA approval · 2017-12-08
  FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

  FDA approved a supplemental application for OMIDRIA, a combination of phenylephrine and ketorolac, from Rayner Surgical Inc.

• FDA approval · 2016-10-27
  FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

  FDA approved a supplemental application for OMIDRIA (phenylephrine and ketorolac) submitted by Rayner Surgical Inc. The approval is related …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-07-08
  FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

  FDA approved a supplemental application for OMIDRIA, a phenylephrine and ketorolac combination, submitted by Rayner Surgical Inc.

• FDA approval · 2016-06-17
  FDA Approved: MIOCHOL E — Supplemental Application (Bausch & Lomb Incorporated)

  The FDA approved a supplemental application for Miochol-E (acetylcholine chloride) submitted by Bausch & Lomb Incorporated.

• FDA approval · 2016-01-15
  FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

  The FDA approved a supplemental application for Omidria (phenylephrine and ketorolac) filed by Rayner Surgical Inc.

• FDA approval · 2015-05-21
  FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

  The FDA approved a supplemental application for OMIDRIA (phenylephrine and ketorolac) from Rayner Surgical Inc.

• FDA approval · 2014-05-30
  FDA Approved: OMIDRIA — Original Application (Rayner Surgical Inc.)

  FDA approved the Original Application for Omidria (phenylephrine and ketorolac) by Rayner Surgical Inc. to maintain pupil dilation during ca…

• FDA approval · 2008-05-08
  FDA Approved: NEVANAC — Supplemental Application (Harrow Eye, LLC)

  FDA approved a supplemental application for NEVANAC (nepafenac) from Harrow Eye, LLC.

• FDA approval · 2006-05-30
  FDA Approved: MIOCHOL E — Supplemental Application (Bausch & Lomb Incorporated)

  FDA approved a supplemental application for Miochol-E (acetylcholine chloride) submitted by Bausch & Lomb Incorporated. The approval pertain…